Granite Point Mortgage Trust Inc. (GPMT), a commercial mortgage REIT specializing in floating-rate loans backed by transitional real estate properties, has endured a brutal decade marked by macroeconomic turbulence. From its 2017 IPO amid a benign rate environment to the COVID-19 shock in 2020 and the subsequent Fed rate-hiking cycle starting in 2022, the company’s trajectory mirrors the volatility of the CRE lending space. What began as a growth story—revenue climbing from $50 million in 2016 to a peak of $125 million in 2020, up 151% over four years—has devolved into a survival tale, with shares languishing near multi-year lows. Yet, glimmers of insider confidence and analyst price targets pointing to 5% to 67% upside from recent levels suggest the narrative might be shifting from despair to cautious rehabilitation.
A Growth Phase Derailed by External Shocks
GPMT’s early years painted a picture of steady expansion. Revenue grew robustly, hitting $109 million in 2019 (19% YoY increase from 2018), fueled by an expanding loan portfolio in a low-rate world. Net income followed suit, reaching $70 million that year (11% higher than 2018), translating to earnings per share (EPS) of $1.32—a key metric for REIT investors gauging distributable income potential. Book value per share (BVPS) stabilized around $19, underscoring a solid equity base with ROE averaging a healthy 7-8%, which signals efficient use of shareholder capital in generating returns.
The 2020 pandemic tested this foundation. Revenue dipped just 14% to $93 million initially in 2021 amid forbearance deals, but EBT flipped to a $40 million loss (-157% swing), highlighting vulnerability to borrower distress. Crucially, gross margins held firm above 87%, a testament to the high-quality, senior-secured nature of GPMT’s loans—important because it reflects low credit provisions relative to interest income in normal times. However, total debt ballooned to $3.7 billion by 2021 (18% YoY rise), amplifying net debt to $3.5 billion and pressuring ROIC to near zero. Shares, trading in the mid-teens historically, began eroding, with low prices falling from $17.80 in 2019 to $9.03 in 2021 (-49%).
The Rate-Hike Reckoning and Portfolio Pain
The real gut punch came post-2022, as the Fed’s aggressive hikes to combat inflation exposed mREITs’ Achilles’ heel: floating-rate assets that repriced higher but were saddled with maturing loans in a high-rate, high-vacancy CRE market. Revenue plummeted 56% to $36 million in 2024 from 2023’s $82 million, correlating tightly with a shrinking portfolio amid repayments and non-renewals. EBT cratered to a staggering -$207 million loss (-228% worse than 2023’s -$63 million), driven by elevated provisions for credit losses—EBT margin diving to -5.77%, a red flag for profitability sustainability.
EPS mirrored this, plunging to -$4.39 in 2024 from -$1.50 in 2023 (-193%), while BVPS eroded 26% to $12.28 from the prior year’s $16.63. ROE turned deeply negative at -30%, underscoring how leverage (PB ratio compressing to 0.23x) amplified equity erosion. Free cash flow per share, a vital REIT gauge for dividend coverage, fell 89% to $0.12 in 2024, reflecting operational strain. Stock prices tracked this downside: highs dropped from $12.33 in 2022 to $6.13 in 2024 (-50%), lows to $2.46 (-52% from 2023), a clear correlation with deteriorating fundamentals amid broader CRE woes like office oversupply post-COVID remote work shifts.
Yet, deleveraging offers a silver lining. Total debt slashed 75% from 2021’s $3.7 billion peak to $875 million in 2024, with net debt down 79% to $761 million—a deliberate pivot to reduce funding costs and risk, critical for restoring investor trust in a sector plagued by Two Sigma and Starwood peers’ blowups.
Insider Activity: A Vote of Confidence at the Bottom
Amid this turmoil, insiders have been net buyers, acquiring roughly twice the shares sold in recent months (733,000 shares bought vs. 303,000 sold). Standouts include the President and CEO scooping up 42,000 shares in May 2025, alongside multiple directors like those adding 50,000+ shares combined that month. August and November saw further director buys totaling 48,000 shares, dwarfing modest sells (e.g., 45,000 shares in November). This activity—clustered when shares hovered near current depressed levels—signals alignment and belief in undervaluation, especially as buys outnumbered sells 2.4:1. For a REIT trading at a 0.21x PB (well below peers’ typical 0.8-1.0x), such moves correlate historically with inflection points, as seen in prior mREIT recoveries like Annaly post-GFC.
No major sells from executives underscore no panic; instead, it’s tactical accumulation, potentially foreshadowing dividend reinstatement (suspended amid losses) or portfolio stabilization.
peering into the Crystal Ball: Analyst Projections and Outlook
Analysts’ forecasts paint a muddled but hopeful path. Revenue is expected to trough at $33.8 million in 2025 (-6% from 2024) before rebounding 11% to $37.5 million in 2026 and 15% to $43.2 million in 2027, driven by selective new originations in a potentially softening rate environment. EPS remains challenged at -$0.74 in 2026 but flips positive to $0.10 in 2027—a modest turnaround implying margin repair. BVPS dips to $11.00 by 2026 (-5% from 2025), but shares outstanding shrink to 47.6 million (-6% from 2024), aiding per-share metrics.
Price targets cluster around modest upside: low-end at ~5% above recent close, mean ~36% higher, high ~67% premium. This implies a forward PE of -2.6x in 2026 (reflecting losses) improving to 19.9x in 2027, reasonable if ROE rebounds toward 1-2%. EV/Sales contracts sharply to 2.5x in 2026 from 62x in 2024, suggesting re-rating potential as leverage normalizes.
Key risks loom: persistent CRE distress (e.g., office defaults up 300% since 2022) could pressure non-performing loans, currently implied in provisions. But tailwinds include Fed pivot expectations—rates peaking could unlock refinancing—and GPMT’s focus on multifamily/industrial (less office-exposed than peers). Management’s track record, post-IPO under steady leadership, plus insider buys, hints at active portfolio curation.
Tying Fundamentals to the Bigger Story
GPMT’s saga is quintessentially REIT: thriving on cheap debt, vulnerable when it spikes. Stock performance inversely mirrored revenue/EBT declines (correlation >0.9 visually), but recent debt reduction (down 19% YoY to 2025’s $715 million) and insider bets suggest capitulation. At ~20% of peak BVPS pricing, it’s a classic deep-value play—PB at 0.21x screams margin of safety, historically yielding 50-100% rebounds in analogs like AGNC.
If rates ease and CRE stabilizes by 2027, expect revenue growth to accelerate, EPS positivity to lure dividend hunters, and shares to mean-target territory (+36%). Downside? Prolonged recession could extend losses, but low leverage buffers that. For patient investors, GPMT’s narrative arc—from boom to bust to buyout candidate?—holds intrigue. Watch Q1 2026 earnings for loan pipeline signals; that’s where the next chapter unfolds.
(Word count: 1,128)